Pulmonary arterial hypertension in France: results from a national registry (Q33993302)

30 July 2017

Pulmonary arterial hypertension in France: results from a national registry (English)

1 reference

30 July 2017

arterial hypertension

1 reference

based on heuristic

inferred from title

author

Martine Reynaud-Gaubert

13

object named as

Martine Reynaud-Gaubert

1 reference

30 July 2017

5

Gilbert Habib

1 reference

30 July 2017

1

Marc Humbert

1 reference

30 July 2017

17

Gérald Simonneau

1 reference

30 July 2017

16

Eric Hachulla

1 reference

30 July 2017

6

Virginie Gressin

1 reference

30 July 2017

3

Ari Chaouat

1 reference

30 July 2017

12

Christophe Pison

1 reference

30 July 2017

11

Claire Dromer

1 reference

30 July 2017

10

François Chabot

1 reference

30 July 2017

8

Emmanuel Weitzenblum

1 reference

30 July 2017

14

Alain Haloun

1 reference

30 July 2017

2

Olivier Sitbon

1 reference

30 July 2017

Jean-François Cordier

9

object named as

Jean-François Cordier

1 reference

30 July 2017

Michèle Bertocchi

4

1 reference

30 July 2017

Azzedine Yaici

7

1 reference

30 July 2017

Marcel Laurent

15

1 reference

30 July 2017

language of work or name

English

0 references

publication date

2 February 2006

1 reference

American Journal of Respiratory and Critical Care Medicine

30 July 2017

1 reference

30 July 2017

173

1 reference

30 July 2017

1023-1030

1 reference

30 July 2017

9

1 reference

Clinical classification of pulmonary hypertension.

30 July 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Diagnosis and differential assessment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Reference equations for the six-minute walk in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Primary pulmonary hypertension associated with the use of fenfluramine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Pulmonary-Hepatic vascular Disorders (PHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Portopulmonary hypertension and hepatopulmonary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200510-1668OC

10.1164/RCCM.200510-1668OC

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference